Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study

By afschroeder • July 6, 2025

Aggarwal R, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Clodi E, Levine T, Charles-Schoeman C; ProDERM investigators. Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study. Rheumatol Ther. 2025 Jul 5. doi: 10.1007/s40744-025-00775-5. Epub ahead of print. PMID: 40616720.

Tags: Arthralgia, Arthritis, Constitutional, Dermatomyositis, gastrointestinal, Immunoglobulins, Intravenous, Octagam, Publications, pulmonary, Rheumatology, Skeletal

Exercise- and Nutrition-Based Prehabilitation Programs in Surgery: A Systematic Review and Meta-Analysis

Cascavita CT, Hall AE, Shariati K, Chevalier JM, Argame AA, Nguyen NH, Tseng CH, Hidalgo MA, Lee JC; Craniofacial Outcomes Research Team. Exercise- and Nutrition-Based[...]

Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer

Mouabbi JA, Lipsyc-Sharf MD, Yan F. Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer. Clin Adv Hematol Oncol. 2026 Jun;24(4 Suppl 4):1-16.[...]

Interpreting MRD results and integrating assays into practice

Lipsyc-Sharf MD. Interpreting MRD results and integrating assays into practice. Clin Adv Hematol Oncol. 2026 Jun;24(4 Suppl 4):7-11. PMID: 42283708.